A Bayesian approach for investigating the risk of QT prolongation

DOI10.1080/15598608.2009.10411936zbMATH Open1211.62182OpenAlexW1998448865WikidataQ42126339 ScholiaQ42126339MaRDI QIDQ2431690FDOQ2431690

Authors: Suraj P. Anand, Sujit K. Ghosh 

Publication date: 18 April 2011

Published in: Journal of Statistical Theory and Practice (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc3157648

Recommendations

• scientific article; zbMATH DE number 1303699
• A Bayesian approach to the analysis of quantal bioassay studies using nonparametric mixture models
• Machine learning in drug development: characterizing the effect of 30 drugs on the QT interval using Gaussian process regression, sensitivity analysis, and uncertainty quantification
• Bayesian Approach to Average Bioequivalence Using Bayes' Factor
• Publication:3484242

zbMATH Keywords

Bayesian inferenceMonte Carlo simulationICH E14QT/QTc intervalthorough QT/QTc study

Mathematics Subject Classification ID

Bayesian inference (62F15) Applications of statistics to biology and medical sciences; meta analysis (62P10) Monte Carlo methods (65C05)

Cites Work

• Title not available (Why is that?)
• Title not available (Why is that?)
• Bioequivalence and statistics in clinical pharmacology.

Cited In (1)

• Machine learning in drug development: characterizing the effect of 30 drugs on the QT interval using Gaussian process regression, sensitivity analysis, and uncertainty quantification

This page was built for publication: A Bayesian approach for investigating the risk of QT prolongation

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2431690)